A pilot, multi-dose, placebo-controlled evaluation of american ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N03CA Barton, D. L. , Soori, G. S. , Bauer, B. , Sloan, J. , Johnson, P. A. ... - - J. Clin. Oncol. - 2007 Abstract - Primary - Primary - Symptom Inter - N03CA
Patient satisfaction with participation in phase II/III NCCTG clinical trials: Was it worth it? (N0392) Chauhan, C. , Atherton, P. J. , Satele, D. , Dueck, A. C. ... - ASCO - J. Clin. Oncol. - 2012 Abstract - Primary - Primary - Health Outcome - NCCTG-N0392
A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422) Jatoi, A. , Schild, S. E. , Foster, N. , Henning, G. T. ... - - Ann Oncol - 2010 Manuscript - Primary - Primary - Respiratory - NCCTG-N0422
Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1 Loprinzi, C. L. , Reeves, B. N. , Dakhil, S. R. , Sloan, J. A. ... - - J. Clin. Oncol. - 2011 Manuscript - Primary - Primary - Health Outcome - N08C1
PET Scan Results of NCCTG N0489: Epratuzumab and Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone Chemotherapy (ER-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Micallef, I. N. , Maurer, M. J. , Witzig, T. E. , Nikcevich, D. ... - ASH - ASH Annual Meeting Abstracts - 2009 Abstract - Secondary - Primary - Lymphoma - NCCTG-N0489
A phase II study of the VEGFR inhibitor pazopanib (P) in patients with newly diagnosed or relapsed malignant pleural mesothelioma (MPM): an NCCTG study Molina, J. R. , Mandrekar, S. J. , Ziegler, K. L. Allen ... - - J Thorac Oncol - 2009 Abstract - Primary - Primary - Respiratory - NCCTG-N0623
N0937 (Alliance): Final clinical results and correlative data from the phase II trial of cisplatin (C) and the novel agent brostallicin (B) in patients with metastatic triple-negative breast cancer (mTNBC) Moreno-Aspitia, A. , Liu, H. , Hillman, D. , Rowland, K. M. Jr ... - ASCO - J. Clin. Oncol. - 2013 Abstract - Primary - Primary - Breast - N0937
N0937 (Alliance): Preliminary results of a phase II clinical trial of cisplatin and the novel agent brostallicin in patients with metastatic triple negative breast cancer (mTNBC) Moreno-Aspitia, A. , Rowland, K. M. Jr , Allred, J. B. , Liu, H. ... - AACR - Cancer Res. - 2012 Abstract - Primary - Preliminary - Breast - N0937
Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1 Reeves, B. , Dakhil, S. R. , Sloan, J. A. , Kamal, A. , Wolf, S. L. ... - - J. Clin. Oncol. - 2010 Abstract - Primary - Primary - Health Outcome - N08C1
Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies. Schild, S. E. , Qi, Y. , Tan, A. D. , Mandrekar, S. J. , Adjei, A. A. ... - - J. Clin. Oncol. - 2008 Abstract - Secondary - Primary - Respiratory - NCCTG-N0424
